Bristol-Myers Squibb's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Bristol-Myers Squibb (BMY)

Q4 2011 Earnings Call

January 26, 2012 10:30 am ET

Executives

Charles Bancroft - Chief Financial Officer, Executive Vice President and Member of Management Council

Giovanni Caforio - President of U.S. Pharmaceuticals

Beatrice Cazala - Executive Vice President of Commercial Operations

Compare to:
Previous Statements by BMY
» Bristol-Myers Squibb's CEO Discusses Q3 2011 Results - Earnings Call Transcript
» Bristol-Myers Squibb's CEO Discusses Q2 2011 Results - Earnings Call Transcript
» Bristol-Myers Squibb's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Elliott Sigal - Chief Scientific Officer, President of Research & Development, Executive Vice President, Member of Management Council, Director, Member of Executive Committee and Member of Science & Technology Committee

Lamberto Andreotti - Chief Executive Officer, Member of Management Council, Director, Member of Science & Technology Committee and Member of Executive Committee

John Elicker - Investor Relations Executive

Analysts

Charles Anthony Butler - Barclays Capital, Research Division

David Risinger - Morgan Stanley, Research Division

Mark J. Schoenebaum - ISI Group Inc., Research Division

Seamus Fernandez - Leerink Swann LLC, Research Division

Tim Anderson - Sanford C. Bernstein & Co., LLC., Research Division

Jami Rubin - Goldman Sachs Group Inc., Research Division

Christopher Schott - JP Morgan Chase & Co, Research Division

John T. Boris - Citigroup Inc, Research Division

Catherine J. Arnold - Crédit Suisse AG, Research Division

Presentation

Operator

Good day, and welcome to today's Bristol-Myers Squibb 2011 Fourth Quarter Earnings Conference Call. This call is being recorded. At this time, I would like to turn the call over to Mr. John Elicker, Senior Vice President, Investor Relations. Please go ahead, Mr. Elicker.

John Elicker

Thank you, Alicia, and good morning, everybody. Thanks for joining us on the call today to discuss our fourth quarter results. Joining me this morning are Lamberto Andreotti, our Chief Executive Officer; Charlie Bancroft, our Chief Financial Officer, and they'll have prepared remarks. And then joining also for Q&A, Elliott Sigal, our Chief Scientific Officer; Beatrice Cazala, our Commercial Lead for Global Commercialization, as well as responsibility for Europe; and Giovanni Caforio, who runs our U.S. business.